Gonorrhea in Men Sex Men and Heterosexual Men by Ángela María Rosa Famiglietti & Susana Diana García
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
3 
Gonorrhea in Men Sex  
Men and Heterosexual Men 
Ángela María Rosa Famiglietti and Susana Diana García 
Faculty of Pharmacy and Biochemistry 
University of Buenos Aires 
Argentina 
1. Introduction 
Gonorrhea is a sexually transmitted infectious disease known since ancient times, with 
biblical (Old Testament) references. The etiologic agent is Neisseria gonorrhoeae, commonly 
called gonococcus. N. gonorrhoeae has accumulated mechanisms of antimicrobial resistance 
so that from the year 2007 it joined the list of multi-resistant, informally called “Superbugs” 
(Shafer in Neisseria Molecular Mechanisms of Pathogenesis, 2010).  
1.1 General description 
Neisseria gonorrhoeae was described by Neisser in 1879 and first cultivated in 1882 by 
Leistikow and Loeffler. At this time, members of the genus Neisseria are classified in the 
family Neisseriaceae with the genera Kingella, Eikenella, Simonsiella, and Alysiella. This family 
is now placed in the ǃ-subgroup of the Phylum Proteobacteria (Janda and Gaydos in Manual 
of Clinical Microbiology, 2007). 
N. gonorrhoeae is a gram-negative diplococci with adjacent sides flattened, like coffee beans, 
do not form spores, oxidizes dimethil or tetramethil-phenylenediamine (oxidase test 
positive) and catalase positive (superoxol test with 30% H2O2); not to reduce nitrites. It may 
grow optimally at 35-37ºC, but it’s unable to grow at low temperature (22ºC). The most of 
gonococcus have an obligate requirement for CO2 (5%) and humidity of 70-80%, it does not 
tolerate drying out. Clinical specimens should be collected with Dacron or rayon swabs. 
These swabs should be inoculated immediately on appropriate media. Calcium alginate 
may have inhibitory effect and cotton swabs contain fatty acids that inhibit the growth of 
gonococci. N. gonorrhoeae grows on selective media, modified Thayer Martin, as Neisseria 
meningitidis. Cysteine is an essential aminoacid for their growth. Some strains have specific 
requirements of certain amino acids, pyrimidines and purines as a result of defective or 
altered biosynthetic pathways. These particular nutritional requirements form the basis for a 
typing method for gonococci called auxotyping. N. gonorrhoeae differs from other species of 
the genus by oxidizing glucose and do not use maltose, sucrose, lactose or fructose in 
cysteine-tryptic digest semisolid agar-base medium (CTA) containing 1% carbohydrate and 
a phenol red pH indicator, or rapid carbohydrate test; not to reduce nitrites and their 
inability to grow at low temperatures (22ºC). 
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The use of enzyme substrates that demonstrate the presence of prolyl-hydroxyprolyl 
aminopeptidase and the abscense of ǃ-galactosidase and Ǆ-glutamyl aminopeptidase also to 
confirm the identification. Currently there are commercially available rapid tests to confirm 
the isolation of N. gonorrhoeae such as immune reactions by using fluorescent monoclonal 
antibodies or coagglutination tests, as well as molecular techniques using specific probes or 
specific primers (Janda and Gaydos in Manual of Clinical Microbiology, 2007). 
1.2 Transmission and clinical manifestations 
N. gonorrhoeae is an exclusive human pathogen and this is their only reservoir. The 
transmission is from person to person through sexual intercourse, so the primary infection 
in adults is installed in the genital area, anal and/ or pharynx, where there is susceptible 
epithelium: cubic or cylindrical not stratified. 
In males, N. gonorrhoeae causes an acute urethritis with dysuria and urethral discharge. 
The incubation period averages 2 to 7 days. About 2.5 to 5 % of men are asyntomatic. 
Complications of untreated gonococcal urethritis are: epididymitis, periurethral abscesses, 
infections of the Tyson’s glands and Cowper’s glands, orchitis and prostatitis (Janda and 
Gaydos in Manual of Clinical Microbiology, 2007). In women, gonococcal infections cause 
cervicitis, only approximately half of which occur with symptoms and which can go on to 
cause pelvic inflammatory disease, ectopic pregnancies, and infertility. In addition, in 
both men and women exposed orally or anally, gonococcal infections can cause a 
predominantly asyntomatic pharyngitis or proctitis. Less commonly, N. gonorrhoeae can 
cause conjunctivitis, endocarditis, tenosynovitis, arthritis, meningitis, inflammation of the 
liver capsule and disseminated blood stream infections (Barry, 2009). 
Conjunctival infection occurs in adult and neonatal by accidental inoculation  
or contamination in the birth canal and causes ophthalmia neonatorum, which if not  
treated properly can lead to blindness (Marrazo in Principle and Practice of Infections  
Disease, 2010). 
Asymptomatic infection in women has been linked to the biofilm production, which 
includes nature complex mixes of exopolysaccharides, proteins and DNA. Bacteria living in 
biofilms are more resistant to biocides and antimicrobial agents. Also, the horizontal transfer 
of resistance genes is more likely and increases the spread of resistance genes (Apicella in 
Neisseria Molecular Mechanisms of Pathogenesis, 2010). Gonococcal infection may facilite 
transmission of human immunodeficiency virus (HIV), increasing the number of target cells 
for HIV in the inflammatory exudate present in symptomatic patients (Bala, 2010) 
1.3 Diagnosis of gonococcal infections 
Diagnosis of gonococcal infection has historically been a combination of clinical signs and 
symptoms plus the microbiologic study. The diagnosis of urethritis in men can be made by 
observing gram-negative intracellular diplococci associated with polymorphonuclear 
leukocites on a smear prepared from the urethral discharge. The Gram stain has a sensitivity 
of 90 to 95% and specificity of 95 to 100% for diagnosing genital gonorrhea in symptomatic 
men. In cervicitis, the sensitivity of this test is less than 50%, when compared with properly 
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performed culture. Culture on selective media, modified Thayer Martin, it allows recovery 
of N. gonorrhoeae from body sites harboring an endogenous bacterial flora. 
At the last years, nucleic acid detection techniques allow direct detection of N. gonorrheae in 
clinical samples and do not require viable organisms. The assay may be divided into three 
types: (i) direct detection probe hybridization to the target nucleic acid with direct detection 
of the hybrid; (ii) nucleic acid amplification tests (NAATs); and (iii) amplified-signal probe 
test, which hybridize with nucleic acid and then amplify the signal of the probe. These 
assays are generally much more sensitive that culture and are highly specific for urogenital 
infections, however, depending on the assay used (e.g. PCR) some concerns have arisen 
about the specificity of these tests from other anatomic sites. The advantages of the test are 
specimens may be transportes from geographically distant areas and stored for several days 
prior to testing. The NAATs also allow use non-invasive specimen types such as urine and 
vaginal swabs. The disadvantages of using nonculture nucleic acid probe or amplification 
tests include unavailability of a viable isolate for antimicrobial susceptibility testing and the 
possibility of a positive test after treatment, since nucleic acids from organism may persist 
for a period of time after successful therapy (Barry, 2009). 
1.4 Epidemiology of gonococcal infections 
Gonococcal infection is more common among young persons, particularly those aged 15-24 
years, persons with lower socio-economic status, men who have sex with men (MSM), illicit 
drug users, commercial workers an racial/ethnic minority groups (Barry, 2009). 
Gonococcal infections are among the most common reportable infections around the World. 
In the Unite Stated, gonorrhea is consistently the second-most frequently reported notifiable 
infection with more than 350,000 reported in 2006 (Barry, 2009; CDC, 2006).  
In the United States, some European countries and Australia, the incidence of gonorrhea 
decreased at the end of the 1.980s to mid of 1.990s it was mainly attributed to changes in 
sexual behaviour produced after the appearance of HIV and the introduction of 
fluoroquinolone treatment (Famiglietti, 2000; Griemberg, 1997; Trotter in Neisseria Molecular 
Mechanisms of Pathogenesis, 2010). 
Gonococcal infection has increased over previous years, although not consistently in all 
countries. In the United States the incidence of gonorrhea in recent years shows an upward 
trend, while the rate of gonorrhea in 2009 decreased 10.5% respect 2008 (Diez, 2011). 
The World Health Organization (WHO) estimated that, globally, there were 62 million new 
cases of gonorrhea in 1999, with 27 million (44%) in South and South-East Asia, 17 million 
(27%) in Sub-Saharan Africa and 7.5 million (12%) in Latin America and the Caribbean 
(WHO, 2001). 
2. Currents problems 
2.1 Neisseria gonorrhoeae: Antimicrobial resistance and clinic impact 
The penicillin introduction by the end of 1940s led to the eradication of N. gonorrhoeae 
sulfonamides resistant and it was the antimicrobial agent that kept its effectiveness for 
nearly forty years (approximately 1945-1985), although it required increasing the dose in 
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response to the emergence of chromosomal resistance and the use of alternative drugs for 
the treatment of isolates penicillinase producers (PPNG), since its appearance in 1976 
(Ashford, 1976). In the mid of 1980s the prevalence of these strains exceeded 40% for what 
should no longer be used for empiric treatment of gonorrhea. At that time, the percentage of 
isolates tetracycline resistant was high, greater than 50% (Famiglietti, 2001). To the high 
prevalence of isolates with chromosomal resistance to tetracycline (CMRNG), originated in 
1970, joined the plasmid resistance (TRNG) which is mediated by the tetM determinant in 
conjugative plasmid that confers high level resistance (Morse, 1986). 
The market introduction of fluoroquinolones in the middle of 1980s, was the ideal 
replacement of penicillin, not only be used as a single-dose and would be highly effective, 
but also has advantage on the route of administration of drug and fewer adverse effects. 
In the United States, due to increased resistance to penicillin and tetracycline, the Centers for 
Disease Control and Prevention (CDC) recommended the use of extended- spectrum 
cephalosporin or a fluoroquinolone as firt line treatment for the uncomplicated gonococcal 
infection (CDC, 1993). 
The use of highly effective fluoroquinolone against PPNG helped limit rapid spread of these 
strains (Janda and Gaydos in Manual of Clinical Microbiology, 2007). However, in 1986 
resistance to enoxacin was reported in Netherlands and the first treatment failures to 
fluorquinolones were documented in Japan in 1.994. (Tapsall, 1992; Deguchi, 2010). Such 
isolates emerged in Argentina in 2000 (Fiorito, 2001). 
At the last years, the emergence of N. gonorrhoeae resistant to fluoroquinolones reintated the 
global problem of the treatment and control of gonorrhea (Update CDC, 2007). The increase 
followed a kinetics up more often affecting men who have sex with men (MSM), but then 
also was extended to heterosexuals men (HET) Figure 1 (CDC,2004; García 2008). MSM 
constitute the most important sources of transmission to sexual contacts from extragenital 
infections (rectum and pharynx), which are often asymptomatic. The high incidence of these 
strains forced a change in the empirical treatment of gonorrhea by cephalosporins, initially 
in MSM and their contacts, and later in the heterosexual men (CDC, 2006, 2010). 
About macrolides, since its introduction in 1952, erythromycin was used for the treatment of 
various infections with an acceptable degree of adverse effects. In 1975 it was recommended 
as treatment for gonorrhoea in pregnant women allergic to penicillin (U.S. Public Health 
Service, 1975). In 1977, it was observed a decline in the drug effectiveness (Brown, 1977). 
Azithromycin is an azalide, structurally and pharmacologically related with erythromycin. 
It was recommended for the treatment of infection caused by Chlamydia trachomatis, a single 
dose of 1 g orally, while for gonorrhea is used in a higher dose (2g) (CDC, 2002). 
Given that N. gonorrhoeae, easily develops resistance to antimicrobial agents and its rapid 
spread, the WHO and CDC recommend changing the treatment regimen when the 
prevalence of antimicrobial resistance is> 5% (WHO, 2003). 
Currently, the CDC recommends for the treatment of uncomplicated gonorrhea and 
infections located in the cervix, urethra and rectum, ceftriaxone 250 mg IM in one dose or 
cefixime 400 mg associated with azithromycin 1g VO or doxycycline 100 mg / day for 7 
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days , VO (CDC, 2010). However there are regions where resistance to cefixime does not 
allow its use (Barry, 2009). 
Azithromycin and doxycycline are intended to cover the presence of Chlamydia trachomatis 
non gonococcal urethritis . The recommended dose of azithromycin for treatment of 
gonorrhea is 2g VO to prevent the emergence of resistance (CDC, 2010). 
About the antimicrobial agents which are recommended by the CDC, there were treatment 
failures with azithromycin when it was given in a single dose of 1g VO for uncomplicated 
gonorrhea, with isolates had MICs between 0.125 and 0.5 µg / ml (Zarantonelli , 1999; Ehret, 
1996). Recently, in several countries are emerging of high-level resistance to azithromycin 
strains (Galarza 2009; Palmer, 2008; Chisholm, 2009; Starnino, 2009). 
Ceftriaxone (third-generation cephalosporin, parenteral) retains its activity against N. 
gonorrhoeae, but recently have been appearing isolates with decreased sensitivity in various 
regions of the world (Martin, 2006; Barry, 2009, Tapsall, 2009; Chisholm, 2010; Deguchi, 
2010; Garcia, 2010a). 
3. Present study with review of literature 
3.1 Incidence of gonorrhea 
The STD Program of the National Hospital of Clinics, “José de San Martín” University of 
Buenos Aires, Argentina, deals with 80% patients from the city and 20% from the suburban 
areas. In a period of 10 years (2000-2009), was investigated the presence of Neisseria 
gonorrhoeae in 4273 male patients (52% MSM and 48% HET). 
The average age of MSM was 33 years (range 14-75 years) and HET was 34 years (range 15-
82 years). The incidence of gonorrhea was 10.3% and 9.5% in MSM and HET respectively 
(p> 0.05) and it was more frequent in men between 20 and 29 years old in both groups of 
patients. 
In MSM urethral location was the most frequent (70%), followed by rectal (34%) and lastly 
the pharynx (17%). This increase in the incidence of gonorrhea in HET in 2008 and 2009 
compared to 2007, was significant (p <0.05) and has also been reported by other authors 
(Velicko, 2009). It could be due to increased in this population of N. gonorrhoeae 
fluoroquinolone resistant in this population, since it was initially installed in the MSM. 
Fluctuations were observed in the annual incidence of gonorrhea in MSM and heterosexual 
men between 1995 and 2009, with a decrease at the end of the 1990s and beginning of the 
new millennium but then it continued to increase slowly in recent years, specially among 
heterosexual men. 
The analysis of results was divided into two periods: 2000-04 (first period), the emergence of 
N. gonorrhoeae fluoroquinolone resistant in 2005 in our Hospital pointed the beginning of the 
second period: 2005-09 (second period). The Table 1 shows the incidence of N. gonorrhoeae 
from clinical specimens according to patient’s sex habits. 
The National Health Surveillance of the Ministry of Health of Argentina (SNVS) had 
registered 28.517 and 17.017 cases of gonorrhea in the periods 2000-4 and 2005-09 
respectively. 
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 Heterosexual men MSM 
 N° Location N° Location 
P
er
io
d
 
Patients 
Positive 
(%) 
Urethra Patients 
Positive 
(%) 
Urethra Rectum Pharinx 
2000-
04 
1259 100 (7.9) 100 1143 117 (10.2) 78 45 15 
2005-
09 
802 95 (11.8) 
94 
Joined (1) 
1069 111 (10.4) 81 33 24 
Total 2061 195 (9.5) 195 2212 228 (10.3) 159 78 39 
 
 
 
 
Table 1. Number and percentaje of gonorrhea cases in males according their sexual habits 
and location sites. 
3.2 Antimicrobial resistance 
All isolates were tested for beta lactamase by chromogenic cephalosporin Nitrocefin method 
(Cefinase BBL. Beckton Dickinson). Over 324 isolates of N. gonorrhoeae was determined the 
minimum inhibitory concentration (MIC) of several antimicrobial agents by the agar 
dilution method according to the recommendation of Clinical Laboratory Standard 
Iinternational (CLSI, 2009). 
3.2.1 Penicillin  
The mechanisms of resistance to penicillin are the production of ǃ-lactamase (penicillinase), 
chromosomal resistance by altering PBP1 and 2, reduced income and increased efflux. 
During periods 2000-04 and 2005-09 the global prevalence of N. gonorrhoeae ǃ- Lactamase 
positive (PPNG) was 8.3% and 12.6%, and chromosomal resistance (CMRNG) was 4.2% and 
23.7% respectively. A significant increase of N. gonorrhoeae with chromosomal resistance to 
penicillin was observed for both groups of patients (p<0.05) in the second period, the results 
are showed in table 2. 
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Períod/SH 
total Nº 
CMRNG% PPNG% 
isolates 
2000-04    
MSM 117 6.8 10.2 
HET 100 1.0 6 
Total 217 4.2 8.3 
2005-09    
MSM 111 33.3 7.2 
HET 95 12.6 18.9 
Total 206 23.7 12.6 
Table 2. Prevalence of Neisseria gonorrhoeae resistant to penicillin 
Whereas the number of isolates ǃ- lactamase positive (PPNG) among MSM decreased (p> 
0.05) between first and second periods, the prevalence of chromocomal resistance (CMRNG) 
to penicillin was significantly higher than HET (p<0.05). It could be related to the rectal 
location, since the environment is rich in fatty acids and hydrophobic molecules that can act 
as a positive selection factor favoring the emergence of resistant strains (Mtr phenotype) 
(García, 2011). 
Resistance to penicillin founded is within the range of Argentine national data (Galarza, 2010). 
3.2.2 Tetracycline 
Plasmid tetracycline resistance is mediated by the tet M determinant (MIC ≥ 16 µg/ml) 
while chromosome type resistance involves the modification of ribosomal protein (S10-Val 
57) (MIC ≥2 µg/ml) ( Shaffer in Neisseria Molecular mechanisms of Pathogenesis, 2010). 
The resistance was higher in the second period for both groups (p>0.05) (figure 1). 
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Fig. 1. Percentage of chromosomal and plasmid resistance to tetracycline. 
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Isolates with low-level resistance to tetracycline (MIC <16 µg / ml) had no cross-resistance 
to minocycline (CIM: 0062-4 µg / ml) (García, 2010a, 2011) 
Tetracycline showed little activity. The plasmid resistance was uncommon (5 / 324), as in 
other regions of Argentina (Galarza, 2010b).  
In figure 1 are shown the plasmid and chromosomal resistance to tetracycline in both 
groups of patients. 
3.2.3 Spectinomycin 
In 2005-09 period a 11% of the isolates showed intermediate sensitivity to spectinomycin 
(MIC = 64 µg / ml), 80% of cases from MSM (García, 2010a, 2011). However, the Argentina 
national data showing 100% sensitivity, but in South Africa was found 33.4% resistance to 
this antimicrobial (Govender, 2006). 
Spectinomycin is effective for the treatment of anogenital gonorrhea but is not useful for 
pharyngeal infection. Besides N. gonorrhoeae can rapidly develop resistance of high-level 
resistance by a single mutation, it was documented in the U.S., Korea and United Kingdom 
(Reyn, 1973; Ashford, 1981; Barry, 2009). 
3.2.4 Emerging of antimicrobial resistance 
The emerging resistance of N. gonorrhoeae in the last decade is to erythromycin, 
azithromycin, fluoroquinolones and decreased sensitivity to ceftriaxone.  
In N. gonorrhoeae were identified four efflux pumps: MtrCDE, FarAB, MacAB, and NorM 
that belong to the families RND, MF, ABC and MATE respectively. Only a few gonococci 
mef gene was detected (Shafer in Neisseria Molecular Mechanisms of Pathogenesis, 2010). 
3.2.4.1 Resistance to erythromycin and azithromycin 
Resistance to macrolides and azalides in N. gonorrhoeae may be due to different mechanisms: 
overexpression of efflux pumps, alteration of the target site, decreased outer membrane 
permeability and inactivation of the drug. 
Of the efflux pumps, MtrCDE, MacAB and NorM recognized relevant antibiotics to treat 
gonorrhea. Protein efflux pump encoded by the mef gene can also recognize macrolides. The 
mef gene is located on a conjugative transposon, but has been found in a limited number of 
gonococci (Luna, 2002). 
The MtrCDE-efflux pump can export erythromycin, tetracycline, penicillin, and 
hydrophobic compounds including fatty acids, bile salts, steroids and antibacterial 
peptides (Morse, 1982, Hagman, 1995), while the pump NorM exports quinolones 
(Rouquette-Loughlin, 2003) and MacAB pump exports macrolides (Rouquette- 
Loughlin, 2005) 
The expression of genes encoding the bacterial efflux depends of several regulatory levels. 
The loss of regulatory systems can result in high levels of antimicrobial resistance. 
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The mtrCDE operon has three genes encoding each of the proteins that make up this 
bomb: MtrC (fusion protein) and MtrR (cytoplasmic membrane protein), MtrE (outer 
membrane protein). 
The complex of genes mtrCDE represents a transcriptional unit is located 250 bp upstream 
and divergently transcribed respect to mtrR gene, which is the gene that encodes a 
regulatory protein MtrR (repressor) of mtrCDE transcription (Lucas, 1997). 
The MtrR protein negatively regulates transcription of the mtrCDE operon, it binds to DNA 
in the region of 250 bp separating the genes mtrR and mtrC, a region where is the promoter 
of the operon transcription. In clinical isolates were found mtrR mutations that alter the 
repressor protein and its binding to DNA, resulting in decreased repression of the mtrCDE 
operon (Lucas, 1997). 
These mutations are found in the region between residues 32 and 53 that make up the 
domain helix-turn-helix protein in the DNA binding and mutations "missense" causing 
A39T amino acid replacement (replacement of alanine by threonine in position 39) or G45D 
(replacement of glycine by aspartic acid at position 45) can increase the resistance to 
hydrophobic antimicrobial presumably because avoid the binding of the MtrR repressor 
protein to DNA up stream on mtrCDE . Another mutation described in clinical isolates is 
one that occurs in the middle of the coding sequence of mtrR: H105Y  
(Replacement of histidine by tyrosine at position 105) or in the C-terminal domain that can 
impact the function of MtrR probably by altering the formation of multimer MtrR (Shafer, 
1995; Warner, 2008). 
There are differences in the level of resistance conferred by mutations, the "missense" 
mutations in the coding sequence typically result in low to intermediate level of resistance 
while mutations in the promoter are associated with high level of resistance (Warner, 
2008). 
Another mechanism of regulation of this efflux system is exercised by a region of inverted 
repeats of 13 bp in the mtrR gene promoter, it has a function as a transcriptional control 
element cis type. In laboratory mutants and clinical isolates was found that the deletion of 
one base pair A: T in this region causes an increased expression of mtrCDE operon and 
repression of mtrR gene transcription, it confers low-level resistance to tetracycline , 
erythromycin, penicillin and hydrophobic agents such as crystal violet, fecal lipids, bile 
salts, detergents (Eg: Triton X-100, nonoxynol-9) (Hagman, 1995) In these cases, 
erythromycin and azithromycin MICs were up to 2 µg / ml and 0.5 µg / ml respectively 
(Zarantorelli, 2001, Cousin, 2003). 
Previous studies indicate that isolates of N. gonorrhoeae from MSM were more resistant 
compared to inhibition by a variety of structurally different hydrophobic compounds, 
including fecal lipids, bile salts, detergents (eg, Triton X-100) and hydrophobic antibiotics 
(eg: erythromycin). It has been attributed to mutations in the efflux system of multiple 
transferable resistance(Mtr) resistance to erythromycin and Triton X-100, it can serve as a 
phenotypic marker for resistance mediated by Mtr in N. gonorrhoeae (Morse, 1982; 
Zarantonelli, 1999). 
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There is clinical evidence to suggest that efflux pumps increase the capacity of gonococci to 
survive during human infection. First, mtrR mutants are isolated frequently from rectum of 
infected patients presumably because it environment is rich in hydrophobic compounds 
such as long chain fatty acids (Morse, 1982). 
Another mechanism is described in gonococcal is the ribosomal rRNA methylation by 
methylases, thereby blocks the binding site of macrolides by methylation in 23 S rRNA in an 
adenosine residue at position 2058 (in E.coli), it site is the domain of the peptidyl transferase 
(Leclerq and Courvalin, 1991). 
In N. gonorrhoeae have been identified enzymes rRNA methylases encoded by the genes 
ermB, ermC, ermF and recently ermA (Roberts, 1999; Chen, 2010). 
The genes encoding rRNA methylase may be in conjugative transposons and they may 
confer to gonococci highly level of resistance to erythromycin (4-16 µg / ml) or decreased 
sensitivity to azithromycin (1 - 4 µg / ml) without mutations in mtrR (Roberts, 1999; Shafer, 
in Neisseria Molecular Mechanisms of Pathogenesis, 2010)  
In recent years the study of strains highly resistant to azithromycin revealed another 
mechanism of resistance due to mutations in the gene encoding the "loop" domain V of 23S 
rRNA peptidyl transferase in the 50S subunit of the ribosome (Chisholm, 2010; Galarza, 2010a). 
The outer membrane of gram-negative represents a significant permeability barrier to 
antibiotics, particularly hydrophobic compounds. Different degrees of truncation of LPS 
oligosaccharides (known as lipooligosaccharides [LOS] in Neisseria) can alter the entry of 
hydrophobic molecules (Lucas, 1995). 
There was not agreement between the diffusion and dilution methods for erythromycin and 
azithromycin, which is why we could not recommend break points for diffusion test. 
In our study, erythromycin resistance increased statistically significantly from first to second 
period for MSM 20.8% and 39.8% respectively (p <0.05), while for the HET the difference 
was not significant, 22.9% and 25.0% respectively;(p> 0.05). 
The difference between MSM and HET was not statistically significant (p> 0.05). The activity 
of azithromycin was superior to erythromycin. 
In the second period two isolates of N. gonorrhoeae with erythromycin MICs = 256 µg / ml 
were associated with azithromycin MICs of 4 and 16 µg / ml, the second strain also was 
resistant to tetracycline, penicillin and ciprofloxacin. These findings are consistent with 
those of other regions of Argentina and other countries (Galarza, 2009; Palmer, 2008; 
Starnino, 2009, Chisholm, 2010) and point to the emergence of high-level resistance to 
azithromycin, it has impact public health and would limit the drug as a treatment option for 
gonorrhea. 
In the isolates with Mtr phenotype (MIC of Triton-X100> 2000 µg/ml), the most frequently 
mutation found was a deletion of a base pair A:T in the region of inverted repeats of 13 bp in 
the promoter region and mutations in the coding region of mtrR gene which could be 
associated with overexpression of MtrCDE pump efflux and subsequent macrolide 
resistance as other authors have shown (Morse, 1982; Zantorelli, 2001). It was the only 
mechanism of macrolide resistant found in these isolates (García, 2011). 
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MSM
 
Fig. 2. Percentage of N. gonrrhoeae resistant to erythromycin and azithromycin. 
In recent years there were communications about the finding of gonococci with high level of 
resistance to azithromycin (MIC ≥ 256 µg / ml) in many countries. The first isolation came 
from Argentina in 2001 (Galarza, 2009), and then in Europe: Scotland, 2004, England, Wales 
and Italy 2007 (Chisholm, 2009, 2010, Stamino, 2009). 
The argentine isolate had a MIC > 2048 µg / ml and A2143G mutation was detected in the 4 
allele. This mutation corresponds to A2059G, described previously in Escherichia coli but not 
in gonococci (Galarza, 2010). 
The use of subtherapeutic doses of azithromycin may be the cause of the emergence of 
strains of N. gonorrhoeae resistant to the antimicrobial agents. 
3.2.4.2 Resistance to fluoroquinolones 
In gonococci the most frequently found mechanism is the alteration of the target site of 
fluoroquinolones: mutations in QRDR regions (Quinolone Resistance Determining Region) 
of genes gyrA, gyrB, parC and parE encoding topoisomerase enzymes that translate in 
changes in the amino acids sequence in GyrA and GyrB, subunits of topoisomerase II (DNA 
gyrase) and ParC, subunit of topoisomerase IV. Mutations in gyrB have little significance, 
since low-level confer resistance to nalidixic acid only, whereas, mutations in gyrA and parC 
genes, confer clinical resistance to the fluoroquinolones. Mutations in parC occur only in 
isolates that had at least one mutation in gyrA (Otero, 2002). Mutations in parE is not related 
to high-level resistance to quinolones. 
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Another mechanism is related to the decrease in cytoplasmic concentration of the drug, it 
can occur by overexpression of efflux pumps and reduced permeability. 
The mtrCDE overexpression can confer low-level resistance to fluoroquinolones and 
hydrophobic compounds (Hagman, 1995). 
Other efflux system detected in N. gonorrhoeae , like NorM of Vibrio parahaemolyticus tht 
belonged to the MATE transporter superfamily, it recognizes cationic compounds 
resulting in increased gonococci resistance to norfloxacin and ciprofloxacin (Rouquette-
Loughlin, 2003). 
The phenotype of low resistance may be due to decreased penetration of antibiotic through 
the bacterial cell membrane. The routes of penetration of quinolones through the bacterial 
cell wall are not completely defined, but hydrophilic molecules seem to diffuse through the 
outer membrane of gram-negative porin-type channels (Hooper in Infectious Diseases 
Principles and Practice, 2010). 
In the Hospital of Clinics of the University of Buenos Aires were detected the first isolates 
fluoroquinolone resistant (QRNG) in 2005 and its frequency was increasing in the coming 
years especially in the MSM, this forced a change in empirical therapy later extended to 
heterosexual men (Garcia, 2008). We couldn’t demonstrate epidemiological link among 
cases, excepting two. The percentage of QRNG according to the patient’s sexual habits are 
shown in Figure 3. 
Resistance to ciprofloxacin is extensive to other fluoroquinolone (norfloxacin, ofloxacin, 
gatifloxacin and lomefloxacin).  
The resistance to fluoroquinolones  was associated to multidrug resistance (García 2010b) 
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Fig. 3. N. gonorrhoeae fluoroquinolone resistant along the years. 
www.intechopen.com
 
Gonorrhea in Men Sex Men and Heterosexual Men 
 
59 
In the QRNG the mechanism found was mutations in topoisomerases (subunits GyrA and 
ParC) (García, 2011). 
3.2.4.3 Ceftriaxone decreased sensitivity 
The genetic mechanisms that increase resistance to third generation cephalosporins in N. 
gonorrhoeae have not been fully elucidated, but much of that resistance is due to mosaic penA 
alleles and probably require alterations in PBP, decreased membrane permeability barrier 
and overexpression of efflux pumps. 
N. gonorrhoeae has three PBPs, named 1, 2 and 3. The PBP2 has a 10 times higher affinity for 
penicillin G that PBP1 and is believed to be the site of increased binding to cephalosporins. 
Some alterations in PBP2 were associated with resistance to ǃ-lactams including 
cephalosporins. The most common mechanism associated with resistance to cefixime is 
altered PBP2 (Ameyama, 2002). Recently, penA alleles different from previously known 
strains appeared in increased resistance to third generation cephalosporins such as cefixime 
and ceftriaxone. These alleles encode at least 60 mutations in PBP2 compared to the wild 
strain and they have a mosaic gene organization appears to have been caused by 
recombination with commensal Neisseria genes such as N. perflava, N. sicca, N. cinerea or N. 
flavescens (Ameyama, 2002; Tanaka, 2006). 
It was reported the isolation of N. gonorrhoeae with ceftriaxone MIC = 0.5 µg / ml had the 
mosaic PBP2, but also mutations in ponA (L421P), penB (A120 and A121) and mtrR. They 
hypothesized that the L421P substitution in the gene encoding PBP1 ponA may be important 
in conferring resistance to ceftriaxone. The possible importance of ponA L421P was 
subsequently supported by data Takahata in which strains with the substitution L421P was 
associated with increased cephalosporin MICs, compared with only transformants that had 
the mosaic PBP2 (Takahata, 2006). However, Nicholas found neither the presence or absence 
of ponA affected the MICs of cephalosporins (Nicholas, 2008). 
This indicates that the mosaic is important but not worth enough to generate the high level 
of resistance to cefixime (Barry, 2009). 
penB mutations, in the "loop" of the gene, reduces the permeability to hydrophilic antibiotics 
and is considered related to chromosomal resistance to penicillin, cephalosporins, 
tetracyclines and fluoroquinolones (Tanaka, 2006). 
In our experience, ceftriaxone proved to be more active, however there is an emergence of 
strains with decreased sensitivity (0.125 to 0.25 µg / ml) and the increase of such isolates 
was notable especially in the year 2009. A 100% of the isolates were susceptible to 
ceftriaxone, but the 7.7% showed reduced susceptibility (MIC: 0.125 to 0.25 µg / ml) and did 
not express extended spectrum beta lactamase (ǃLEE) (García, 2010b) 
This situation is similar to other countries, in Australia (2005) 1% of the isolates of N. 
gonorrhoeae had MIC ≥ 0.062 µg / ml; 12.1% in Amsterdam in 2008; 3% in Russia (2004) and 
elsewhere (Tanaka, 2006; Barry, 2009; Martin, 2006). 
In Japan, cefixime therapy failures date back to 2000, it stopped to be used in 2006 and it 
was replaced by ceftriaxone and spectinomycin which are used as first-line drugs for 
empirical treatment of uncomplicated gonorrhea (Barry, 2009). In China, Hong Kong and 
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Taiwan were detected isolates with decreased sensitivity to ceftriaxone and treatment 
failures with ceftibuten. In Vietnam, Thailand and the Philippines have been isolated 
sporadically N. gonorrhoeae with ceftriaxone MICs of ≥ 0.5 µg / ml. In Europe and the U.S. 
were also found isolates of N. gonorrhoeae with ceftriaxone MIC ≥ 0.125 µg / ml. (Barry, 
2009, Martin 2006). 
In Argentina, the first report of isolates of N. gonorrhoeae with decreased sensitivity to 
ceftriaxone came from in the Hospital of Clinics, “José de San Martín”, Universiy of Buenos 
Aires. The emergence of strains with reduced sensitivity to ceftriaxone is an alert to the 
possibility of treatment failure in a short period of time.  
The combination of different mechanisms of resistance in the same strain, or affectation of 
multiple antimicrobial for developing a type of mechanism leads to the emergence of strains 
resistant to several antimicrobial agents simultaneously. Tapsall (2009) defined N. 
gonorrhoeae multi drug resistant (MDR-NG) when the isolate has resistance to a class of 
antimicrobial listed in category I: parenteral Cephalosporins / oral cephalosporins / 
Spectinomycin, plus the resistance of two or more classes of antimicrobial in category II:  
penicillins/ fluoroquinolones/azithromycin/aminoglycosides/carbapenems. 
Extensively-drug resistant N. gonorrhoeae (XDR-NG) include those resistant to two or more 
of the antibiotic classes in category I and three or more in category II. 
In our study 4.3% (14/324) isolates of N. gonorrhoeae were categorized as multiresistant and 
0.3% (1 / 324) resistant gonococci extensively according to the definitions of Tapsall (2009) 
(García, 2011). 
4. Genetic relationship of isolates of N. gonorrhoeae ciprofloxacin resistant 
The characterization of different isolates of N. gonorrhoeae provides the information 
necessary to understand the strains circulating in a community, identify chains of 
transmission, the temporal changes that may occur and the emergence and spread of 
antimicrobial resistance (Rahman, 2001). 
The first methods used were based on phenotypic characteristics, the auxotipificación and 
serotyping; also the profile of antimicrobial resistance and type of plasmids contribute to the 
characterization of strains, but they do so limited, these techniques have less discrimination 
index for delineate strains of a species that genotyping assays. 
Several molecular techniques have been applied to the study of N. gonorrhoeae, ribotyping, 
AP-PCR, REP-PCR, ARDRA, PCR-RFLP, sequencing of the genes opa, TbpB, NG-MAST, 
MLST. Pulsed-field gel electrophoresis (PFGE) is a standard technique for studying 
populations of many bacteria, but it would not be discriminating enough to distinguish the 
great diversity of genotypes expected in a recombinant nonclonal population as N. 
gonorrhoeae (O'Rourke, 1995). 
However, in a study by Van Looveren, 1999, was found that the discriminative power of 
some typing methods for N. gonorrhoeae, defined as the method's ability to differentiate 
unrelated strains (Simpson Index) was higher for PFGE (SI:0.997).  
The election of the technique depends of objective early or late evolution. 
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The most discriminative techniques are multilocus sequence typing (MLST), multiantigen 
sequence typing (NG-MAST), porB-based DNA sequence analysis and PCR-RFLP opa. To 
study isolates during short time periods in order to detected transmission chains, identify 
circulating strains community epidemics, e.g. the elected methods are porB sequence 
analysis and NG-MAST. Furthermore, isolates with identicalDNA sequencing types may be 
further subdivided by using bother high-resolution methods, such as PFGE and Opa typing. 
The family of opa genes evolve rapidly in order to distinguish genetically unrelated strains 
and to demonstrate sexual contacts, as well as the persistence of strains in the community 
present in asymptomatic individuals. 
opa gene analysis is sufficiently discriminative to detect short chains of transmission 
(García, 2011). 
The analysis of different genotypes of N. gonorrhoeae over the years, in the population 
stutied, let we conclude that the increase in quinolone resistance was not due to the spread 
of a single strain. 
Other molecular technique applicable for this purpose to N. gonorrhoeae are MLST and NG-
MAST with discriminatory indices exceeding 0.9 (Tazi, 2010; Morris, 2009). 
5. Conclusion 
In conclusion, selective pressure exerted by antibiotics and the inappropriate use of them 
reflects the high number of N. gonorrhoeae fluoroquinolone resistant is circulating in our 
program area, resistance to erythromycin and azithromycin and the findings of decreased 
susceptibility to ceftriaxone and especinomicina. 
An increase of N. gonorrhoeae fluoroquinolone resistant was detected initially in the MSM 
population that later spread to the HET and based the modification of empiric treatment of 
gonorrhea by ceftriaxone. Be alert to the emergence of gonococci with decreased 
susceptibility to ceftriaxone, which also presented simultaneous resistance to other agents 
and its association with MSM population. 
Currently exist a large number of resistant strains of N. gonorrhoeae fluoroquinolone resistant 
circulating and most of them are not shared between HET and MSM. 
6. Future perspectives 
In view of the widespread emergence of resistant isolates and the multidrug resistance 
profile of N. gonorrhoeae also to emphasize or intensify prevention campaigns among 
young people should be evaluated strategies that can be applied in case of emergence of 
resistance to ceftriaxone. One of them is not yet tested other antibiotics prescribed for the 
treatment of gonorrhea in order to search for drugs up in case of emerging resistance to 
third generation parenteral cephalosporins. There is limited experience in the treatment of 
gonococcal infections with aminoglycosides, these drugs have been used in Asia and 
Africa. No kanamycin resistance was detected but it developed resistance to gentamicin 
when it is used in Malawi (Barry, 2009). In a surveillance study of resistance of N. 
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gonorrhoeae in Europe, 95% of 1366 isolates showed MIC of gentamicin in a narrow range: 
4-8 ug / ml (Chisholm, 2010). 
The frequency of tetracycline resistance is very high and resistance to azithromycin is more 
than 5% and circulating strains with high resistance, so that these drugs would not be 
appropriate to empirical treatment of gonorrhea. 
Spectinomycin, is an aminocyclitol that shows good activity and appear to be among the 
possible treatment in case of resistance to ceftriaxone, but there are gonococci with 
intermediate sensitivity (Garcia, 2010; Barry, 2009). Furthermore, mutations in a single step 
are able to quickly generate resistance and it was checked when spectinomycin was used as 
treatment against PPNG strains. We should also take into account the lack of eradication of 
throat infection (Barry, 2009). 
Tigecycline, glycylcycline derivative of tetracycline, showed in vitro activity against N. 
gonorrhoeae resistant to tetracycline, but there have been no clinical trials for infections 
caused by this organism. Rifampin may be an alternative but quickly generates resistance 
(Barry, 2009). 
Other drugs that could be tested are Lactivicinas (LTV) that inhibits PBPs but their 
structure does not contain the ǃ-lactam ring and thus is resistant to the action of ǃ-
lactamases, are active against clinical isolates of Streptococcus pneumoniae resistant to 
penicillin (Macheboeuf, 2007). 
Medicinal plants like Ocimum sanctum were investigated as possible source of new active 
drugs against N. gonorrhoeae, after extraction and purification of its active ingredient 
"eugenol" tested its activity against N. gonorrhoeae and shown to have antimicrobial activity, 
in view of its efficacy and low toxicity can be a potential molecule to be developed for 
clinical application (Shoken, 2008). 
Some authors suggest the design of drugs to site of action of efflux pumps as they are 
responsible for simultaneous resistance to several antimicrobial (Shafer in Neisseria 
Molecular Mechanisms of Pathogenesis, 2010). 
Other strategies to use would be: I) Increase the dose of cephalosporin, ii) multi-dose 
cephalosporin regimens; III) microbiologically directed treatment, IV) association of 
antimicrobial agents, V) Rotate empirical treatments (Chisolmon, 2010). 
The development a vaccine for N. gonorrhoeae would be effective tool to act from prevention, 
however attempts at developing it were difficult because of the antigenic diversity and 
variability, and the lack of an animal model. Research in these areas will play a large rol in 
the future.  
On the other hand, is not only important to detect carriers but also testing antimicrobial 
susceptibility against the isolation of N. gonorrhoeae from each sites of infection. 
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